Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2015 Jan-Feb;16(1):15-23.
doi: 10.1038/gene.2014.57. Epub 2014 Oct 23.

Genetic analysis of the pathogenic molecular sub-phenotype interferon-alpha identifies multiple novel loci involved in systemic lupus erythematosus

Affiliations

Genetic analysis of the pathogenic molecular sub-phenotype interferon-alpha identifies multiple novel loci involved in systemic lupus erythematosus

S N Kariuki et al. Genes Immun. 2015 Jan-Feb.

Abstract

Systemic lupus erythematosus (SLE) is a chronic autoimmune disorder characterized by inflammation of multiple organ systems and dysregulated interferon responses. SLE is both genetically and phenotypically heterogeneous, greatly reducing the power of case-control studies in SLE. Elevated circulating interferon-alpha (IFN-α) is a stable, heritable trait in SLE, which has been implicated in primary disease pathogenesis. About 40-50% of patients have high IFN-α, and high levels correspond with clinical differences. To study genetic heterogeneity in SLE, we performed a case-case study comparing patients with high vs low IFN-α in over 1550 SLE cases, including genome-wide association study and replication cohorts. In meta-analysis, the top associations in European ancestry were protein kinase, cyclic GMP-dependent, type I (PRKG1) rs7897633 (P(Meta) = 2.75 × 10(-8)) and purine nucleoside phosphorylase (PNP) rs1049564 (P(Meta) = 1.24 × 10(-7)). We also found evidence for cross-ancestral background associations with the ankyrin repeat domain 44 (ANKRD44) and pleckstrin homology domain containing, family F member 2 gene (PLEKHF2) loci. These loci have not been previously identified in case-control SLE genetic studies. Bioinformatic analyses implicated these loci functionally in dendritic cells and natural killer cells, both of which are involved in IFN-α production in SLE. As case-control studies of heterogeneous diseases reach a limit of feasibility with respect to subject number and detectable effect size, the study of informative pathogenic sub-phenotypes becomes an attractive strategy for genetic discovery in complex disease.

PubMed Disclaimer

Figures

Figure 1
Figure 1
Top signals of association with increased serum IFN-α activity in SLE cases in the discovery phase. A) Manhattan plot shows top association signals by chromosome. B) Q–Q Plot showing association of SLE GWAS SNPs with serum IFN-α.
Figure 2
Figure 2
Tissue specific analysis of gene networks in different immune cells. Networks demonstrate relationships between PNP, PRKG1, ANKRD44 and PLEKHF2 to other molecules in immune cells. Edges with weight (relative confidence) greater than 0.4 are shown. Each network diagram represents a different immune cell type as follows: A: B lymphocyte, B: Dendritic cell, C: Monocyte, D: Neutrophil, E: NK cell, F: T lymphocyte.
Figure 3
Figure 3
Principal component analyses to detect population structure. A. and B. show principal components from all SNPs studied in the SLEGEN GWAS data set. All studied subjects are included, and reference populations from HapMap 3 samples are also included. Each circle represents an individual sample. PC = principal component, SLE=SLEGEN samples, CEU=Utah residents with Northern and Western European ancestry from the CEPH collection, CHB=Han Chinese in Beijing, China, JPT=Japanese in Tokyo, Japan, TSI=Toscani in Italy, YRI=Yoruba in Ibadan, Nigeria, AJ=Ashkenazi Jewish. C. and D. show the principal components derived from the AIMs in the replication cohort. Each symbol represents an individual sample, and colors represent self-reported ancestry.

References

    1. Harley JB, Kelly JA, Kaufman KM. Unraveling the genetics of systemic lupus erythematosus. Springer Semin Immunopathol. 2006;28(2):119–30. - PubMed
    1. Ko K, Koldobskaya Y, Rosenzweig E, Niewold TB. Activation of the Interferon Pathway is Dependent Upon Autoantibodies in African-American SLE Patients, but Not in European-American SLE Patients. Frontiers in immunology. 2013;4:309. - PMC - PubMed
    1. Sanchez E, Comeau ME, Freedman BI, Kelly JA, Kaufman KM, Langefeld CD, et al. Identification of novel genetic susceptibility loci in African American lupus patients in a candidate gene association study. Arthritis and rheumatism. 2011;63(11):3493–501. - PMC - PubMed
    1. Ko K, Franek BS, Marion M, Kaufman KM, Langefeld CD, Harley JB, et al. Genetic ancestry, serum interferon-alpha activity, and autoantibodies in systemic lupus erythematosus. The Journal of rheumatology. 2012;39(6):1238–40. - PMC - PubMed
    1. Niewold TB, Hua J, Lehman TJ, Harley JB, Crow MK. High serum IFN-alpha activity is a heritable risk factor for systemic lupus erythematosus. Genes Immun. 2007;8(6):492–502. - PMC - PubMed

Publication types

MeSH terms

Substances